Cargando…
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
The neuraminidase (NA) inhibitors are the only class of antivirals approved for the treatment and prophylaxis of influenza that are effective against currently circulating strains. In addition to their use in treating seasonal influenza, the NA inhibitors have been stockpiled by a number of countrie...
Autores principales: | Leang, Sook-Kwan, Hurt, Aeron C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564701/ https://www.ncbi.nlm.nih.gov/pubmed/28448045 http://dx.doi.org/10.3791/55570 |
Ejemplares similares
-
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018) -
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
por: Takashita, Emi, et al.
Publicado: (2015) -
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
por: Gubareva, Larisa V., et al.
Publicado: (2017) -
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
por: Meijer, Adam, et al.
Publicado: (2014) -
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
por: Hurt, Aeron C., et al.
Publicado: (2016)